Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$360M
1 round on record
Latest round
$360M
Venture round · Jun 2022 · 4 yr ago
Team
501-1000
employees, estimated range
Backers
2
ARCH Venture Partners, GV
The money's age
Long since its last round
52 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 15, 2022 Raised a round Venture round $360M · SEC Form D 2022 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jun 2022 $360M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Areteia Therapeutics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Jorge BartolomeExecutive Officer, DirectorSEC Form D
Christopher CourtsExecutive OfficerSEC Form D
Robin WalkerExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

People

Jorge Bartolome
Executive Officer, Director
Christopher Courts
Executive Officer
Robin Walker
Executive Officer
Paul Berns
Director
Adam Koppel
Director
Ian Read
Director
Benjamin Gomez
Director
Michael Bozik
Director
Stephen Butts
Director
Elyse Stock
Director
Daniel Becker
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Chapel Hill United States
HQ
500-1000 est. staff

Financials

Total raised
$360M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2022 $360M Details